EUROPEAN EXPERT CONSENSUS ON IMPROVING PATIENT SELECTION FOR THE MANAGEMENT OF DISABLING SPASTICITY WITH INTRATHECAL BACLOFEN AND/OR BOTULINUM TOXIN TYPE A.

MLA

Biering-Sørensen, Bo, et al. “European Expert Consensus on Improving Patient Selection for the Management of Disabling Spasticity with Intrathecal Baclofen And/Or Botulinum Toxin Type A.” Journal of Rehabilitation Medicine (Stiftelsen Rehabiliteringsinformation), vol. 54, Jan. 2022, pp. 1–13. EBSCOhost, https://doi.org/10.2340/16501977-2877.

APA

Biering-Sørensen, B., Stevenson, V. L., Bensmail, D., Grabljevec, K., Martínez Moreno, M., Pucks-Faes, E., Wissel, J., & Zampolini, M. (2022). European Expert Consensus on Improving Patient Selection for the Management of Disabling Spasticity with Intrathecal Baclofen And/Or Botulinum Toxin Type a. Journal of Rehabilitation Medicine (Stiftelsen Rehabiliteringsinformation), 54, 1–13. https://doi.org/10.2340/16501977-2877

Chicago

Biering-Sørensen, Bo, Valerie L. Stevenson, Djamel Bensmail, Klemen Grabljevec, Mercedes Martínez Moreno, Elke Pucks-Faes, Joerg Wissel, and Mauro Zampolini. 2022. “European Expert Consensus on Improving Patient Selection for the Management of Disabling Spasticity with Intrathecal Baclofen And/Or Botulinum Toxin Type A.” Journal of Rehabilitation Medicine (Stiftelsen Rehabiliteringsinformation) 54 (January): 1–13. doi:10.2340/16501977-2877.